Marie Depuydt

11PUBLICATIONS
64CO-AUTHORS
Molecular targetsAutoimmunityInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 23, 2026
Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice.

|Oct 07, 2025
Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis.

Megan Mulholland, Anthi Chalou, Samuel H A Andersson

|Apr 26, 2024
Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells.

Marie A C Depuydt, Frank H Schaftenaar, Koen H M Prange

|Apr 25, 2024
Immunoproteasomal Inhibition With ONX-0914 Attenuates Atherosclerosis and Reduces White Adipose Tissue Mass and Metabolic Syndrome in Mice.

Frank H Schaftenaar, Andrea D van Dam, Gerjan de Bruin

|Apr 18, 2024
Resident Memory T Cells in the Atherosclerotic Lesion Associate With Reduced Macrophage Content and Increased Lesion Stability.

Maaike J M de Jong, Marie A C Depuydt, Frank H Schaftenaar

|Apr 02, 2024
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.

Megan Mulholland, Marie A C Depuydt, Gabriel Jakobsson

Pageof 2

Frequent Collaborators

8 joint publications

Bram Slütter

5 joint publications

Jill de Mol

5 joint publications

Ilze Bot

5 joint publications

Johan Kuiper